Suppr超能文献

miR-4319 通过靶向 ABTB1 抑制结直肠癌细胞的进展。

MiR-4319 suppresses colorectal cancer progression by targeting ABTB1.

机构信息

Nanjing Medical University, Nanjing, China.

Department of General Surgery, Wuxi People's Hospital, Wuxi, China.

出版信息

United European Gastroenterol J. 2019 May;7(4):517-528. doi: 10.1177/2050640619837440. Epub 2019 Mar 6.

Abstract

BACKGROUND

Colorectal cancer is one of the highly malignant cancers with a poor prognosis. The exact mechanism of colorectal cancer progression is not completely known. Recently, microRNAs (miRNAs, miRs) were suggested to participate in the regulation of multiple cancer development, including colorectal cancer.

METHODS

MiR-4319 expression in colorectal cancer patient samples was detected by real-time polymerase chain reaction. MiR-4319 was knocked down in the colorectal cancer cells by siRNA transfection to study the role of miR-4319 in the cell cycle and proliferation of colorectal cancer cells.

RESULTS

MiR-4319 expression was found to be inverse correlated with survival in colorectal cancer patients. Overexpression of miR-4319 markedly reduced the proliferation of colorectal cancer cells and altered cell cycle distribution. A further experiment showed that ABTB1 is the target gene of miR-4319. MiR-4319 was regulated by PLZF.

CONCLUSION

Our studies indicated that reduced expression of miR-4319 was correlated with poor prognosis in colorectal cancer patients; miR-4319 also suppressed colorectal cancer cell proliferation by targeting ABTB1. ABTB1 might become an excellent therapeutic target for colorectal cancer treatment.

摘要

背景

结直肠癌是预后较差的高度恶性癌症之一。结直肠癌进展的确切机制尚不完全清楚。最近,microRNAs(miRNAs,miRs)被认为参与了多种癌症的发展调控,包括结直肠癌。

方法

通过实时聚合酶链反应检测结直肠癌患者样本中的 miR-4319 表达。通过 siRNA 转染使结直肠癌细胞中的 miR-4319 敲低,研究 miR-4319 在结直肠癌细胞周期和增殖中的作用。

结果

miR-4319 的表达与结直肠癌患者的生存呈负相关。miR-4319 的过表达显著降低了结直肠癌细胞的增殖并改变了细胞周期分布。进一步的实验表明,ABTB1 是 miR-4319 的靶基因。PLZF 调节 miR-4319。

结论

我们的研究表明,miR-4319 的表达降低与结直肠癌患者的预后不良相关;miR-4319 还通过靶向 ABTB1 抑制结直肠癌细胞的增殖。ABTB1 可能成为结直肠癌治疗的优秀治疗靶点。

相似文献

1
MiR-4319 suppresses colorectal cancer progression by targeting ABTB1.
United European Gastroenterol J. 2019 May;7(4):517-528. doi: 10.1177/2050640619837440. Epub 2019 Mar 6.
2
Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Gastroenterology. 2013 Aug;145(2):426-36.e1-6. doi: 10.1053/j.gastro.2013.04.004. Epub 2013 Apr 9.
3
miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ.
Biosci Rep. 2019 Dec 20;39(12). doi: 10.1042/BSR20190193.
4
miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
World J Gastroenterol. 2014 Jun 7;20(21):6515-22. doi: 10.3748/wjg.v20.i21.6515.
5
MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP.
Oncol Rep. 2018 Jul;40(1):252-260. doi: 10.3892/or.2018.6406. Epub 2018 Apr 30.
6
Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
Med Oncol. 2015 Jan;32(1):362. doi: 10.1007/s12032-014-0362-4. Epub 2014 Dec 13.
8
MiR-769 Inhibits Colorectal Cancer Cell Proliferation and Invasion by Targeting HEY1.
Med Sci Monit. 2018 Dec 19;24:9232-9239. doi: 10.12659/MSM.911663.
10
Inhibits Proliferation and Migration of Colorectal Cancer SW480 Cells.
Anticancer Res. 2017 Aug;37(8):4345-4352. doi: 10.21873/anticanres.11828.

引用本文的文献

1
Exploring miRNA Research in Colorectal Cancer: Insights from a Bibliometric Analysis.
Pharmaceutics. 2025 Aug 21;17(8):1084. doi: 10.3390/pharmaceutics17081084.
2
IFN-γ downregulates miR-4319 to enhance NLRC5 and MHC-I expression in MHC-I-deficient breast cancer cells.
Cancer Biol Ther. 2025 Dec;26(1):2523621. doi: 10.1080/15384047.2025.2523621. Epub 2025 Jul 1.
3
Can thymosin beta 10 function both as a non-invasive biomarker and chemotherapeutic target in human colorectal cancer?
Transl Oncol. 2024 Aug;46:102026. doi: 10.1016/j.tranon.2024.102026. Epub 2024 Jun 7.
4
Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy.
Front Mol Biosci. 2024 Feb 22;10:1297611. doi: 10.3389/fmolb.2023.1297611. eCollection 2023.
5
A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma.
Heliyon. 2024 Jan 19;10(3):e24455. doi: 10.1016/j.heliyon.2024.e24455. eCollection 2024 Feb 15.
6
Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer.
Front Endocrinol (Lausanne). 2023 Apr 18;14:1125299. doi: 10.3389/fendo.2023.1125299. eCollection 2023.
7
NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA.
Oncol Rep. 2023 May;49(5). doi: 10.3892/or.2023.8526. Epub 2023 Mar 17.
8
Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation.
PLoS One. 2023 Feb 21;18(2):e0281645. doi: 10.1371/journal.pone.0281645. eCollection 2023.
9
Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer.
J Cancer Res Clin Oncol. 2023 Aug;149(9):5687-5696. doi: 10.1007/s00432-022-04525-w. Epub 2022 Dec 21.
10
Small Non-Coding RNAs in Human Cancer.
Genes (Basel). 2022 Nov 9;13(11):2072. doi: 10.3390/genes13112072.

本文引用的文献

2
Colorectal cancer survival at an oncologic center in Colombia. A historic cohort study.
Rev Gastroenterol Mex (Engl Ed). 2019 Apr-Jun;84(2):174-184. doi: 10.1016/j.rgmx.2018.04.002. Epub 2018 Jun 6.
6
Fiber Intake and Colorectal Cancer.
JAMA Oncol. 2018 Aug 1;4(8):1135. doi: 10.1001/jamaoncol.2018.0878.
8
Identity, community and care in online accounts of hereditary colorectal cancer syndrome.
New Genet Soc. 2018 May 2;37(2):117-136. doi: 10.1080/14636778.2018.1469974. eCollection 2018.
10
Re-expression of microRNA-4319 inhibits growth of prostate cancer via Her-2 suppression.
Clin Transl Oncol. 2018 Nov;20(11):1400-1407. doi: 10.1007/s12094-018-1871-y. Epub 2018 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验